SLC2A1 and hepatocellular carcinoma: We also found a progressive increase in the expression of SLC2A1 from HCC stage I to IV (from TCGA Database) (Fig. 1E), and the median overall survival time of SLC2A1 high expression group was significantly shorter than that of SLC2A1 low expression group (from TCGA Database) (Fig. 1F).